Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2020
Period Ending	Aug '25 Aug 11, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2020
Market Capitalization	179	259	359	419	412	330	Upgrade
Market Cap Growth	-41.88%	-27.85%	-14.38%	1.74%	24.68%	10.48%	Upgrade
Enterprise Value	756	805	997	1,167	808	755	Upgrade
Last Close Price	17.86	23.01	32.42	34.68	30.68	20.41	Upgrade
PE Ratio	-	-	-	4.12	3.57	12.70	Upgrade
PS Ratio	1.88	2.58	3.20	3.52	4.61	4.12	Upgrade
PB Ratio	0.67	0.91	1.15	0.83	1.08	1.16	Upgrade
P/OCF Ratio	5.01	5.98	11.95	13.00	12.65	12.60	Upgrade
EV/Sales Ratio	7.60	8.03	8.89	9.80	9.04	9.41	Upgrade
EV/EBIT Ratio	20.16	20.36	22.59	23.80	21.04	22.30	Upgrade
Debt / Equity Ratio	2.20	2.16	2.19	1.66	1.70	1.54	Upgrade
Asset Turnover	0.10	0.10	0.09	0.09	0.09	0.11	Upgrade
Quick Ratio	0.52	0.36	1.04	0.67	2.02	3.10	Upgrade
Current Ratio	0.67	0.76	1.09	1.21	2.06	3.16	Upgrade
Return on Equity (ROE)	-5.43%	-4.65%	-27.63%	21.83%	34.52%	9.78%	Upgrade
Return on Assets (ROA)	2.28%	2.36%	2.22%	2.23%	2.54%	2.86%	Upgrade
Return on Capital (ROIC)	2.46%	2.59%	2.43%	2.45%	2.73%	3.05%	Upgrade
Earnings Yield	-8.66%	-5.40%	-30.42%	24.29%	27.98%	7.88%	Upgrade
Dividend Yield	6.74%	-	5.75%	8.28%	6.60%	10.54%	Upgrade
Buyback Yield / Dilution	-	-	-	-	-11.36%	-1.03%	Upgrade
Total Shareholder Return	6.74%	-	5.75%	8.28%	-4.75%	9.52%	Upgrade

Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.